Albane Ledoux‐Pilon
Papers
1
Total Citations
16
H-Index
1
About
Dr. Albane Ledoux‐Pilon is a hematologist-oncologist whose research focuses on the intricate molecular mechanisms underlying myeloproliferative neoplasms (MPNs) and chronic myeloid leukemia (CML). Her most cited work, a 2009 study, made a seminal contribution by demonstrating that a thrombocytosis emerging in a patient with Philadelphia-positive CML in molecular response to imatinib could actually reveal an underlying JAK2V617F-positive MPN. This discovery, cited 16 times, highlighted a critical diagnostic pitfall and advanced the understanding of clonal hematopoiesis and disease coexistence. Dr. Ledoux‐Pilon’s research bridges clinical observation and molecular biology, offering insights into treatment resistance and dual-pathway malignancies. Her work has been instrumental in refining diagnostic algorithms for patients with atypical responses to tyrosine kinase inhibitors, emphasizing the need for vigilant molecular monitoring. Through her meticulous case studies and translational approach, she has provided a framework for identifying hidden MPN clones that can masquerade as treatment-related complications, ultimately improving patient management and outcomes in complex hematologic disorders.
Research Focus
Key Achievements
Top Papers
- 1